Aspen Pharmacare Holdings Limited

OTCPK:APNH.F Stock Report

Market Cap: US$5.9b

Aspen Pharmacare Holdings Management

Management criteria checks 4/4

Aspen Pharmacare Holdings' CEO is Stephen Saad, appointed in Jan 2000, has a tenure of 24.67 years. total yearly compensation is ZAR24.15M, comprised of 38% salary and 62% bonuses, including company stock and options. directly owns 12.84% of the company’s shares, worth $754.54M. The average tenure of the management team and the board of directors is 7.5 years and 5.4 years respectively.

Key information

Stephen Saad

Chief executive officer

R24.1m

Total compensation

CEO salary percentage38.0%
CEO tenure24.7yrs
CEO ownership12.8%
Management average tenure7.5yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Stephen Saad's remuneration changed compared to Aspen Pharmacare Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

R5b

Sep 30 2023n/an/a

R5b

Jun 30 2023R24mR9m

R5b

Mar 31 2023n/an/a

R6b

Dec 31 2022n/an/a

R6b

Sep 30 2022n/an/a

R6b

Jun 30 2022R23mR9m

R6b

Mar 31 2022n/an/a

R6b

Dec 31 2021n/an/a

R6b

Sep 30 2021n/an/a

R5b

Jun 30 2021R24mR8m

R5b

Mar 31 2021n/an/a

R4b

Dec 31 2020n/an/a

R4b

Sep 30 2020n/an/a

R4b

Jun 30 2020R23mR8m

R3b

Mar 31 2020n/an/a

R3b

Dec 31 2019n/an/a

R870m

Sep 30 2019n/an/a

R1b

Jun 30 2019R14mR8m

R2b

Mar 31 2019n/an/a

R3b

Dec 31 2018n/an/a

R5b

Sep 30 2018n/an/a

R5b

Jun 30 2018R17mR7m

R6b

Compensation vs Market: Stephen's total compensation ($USD1.34M) is below average for companies of similar size in the US market ($USD8.26M).

Compensation vs Earnings: Stephen's compensation has been consistent with company performance over the past year.

CEO

Stephen Saad (60 yo)

24.7yrs

Tenure

R24,149,000

Compensation

Mr. Stephen Bradley Saad, BCom, CA(SA), serves as the Group Chief Executive Officer of Aspen Pharmacare Canada Inc. Mr. Stephen has been the Group Chief Executive Officer of Aspen Pharmacare Holdings Limit...

Leadership Team

NamePositionTenureCompensationOwnership
Stephen Saad
Group CEO & Executive Director24.7yrsR24.15m12.84%
$ 754.5m
Sean Capazorio
Group CFO & Executive Director25.7yrsR15.55mno data
Lorraine Hill
Group Chief Operations Officer & Responsible Pharmacist10.8yrsR16.59mno data
Michael Attridge
Group Chief Advisor2.7yrsR12.62m4.31%
$ 253.5m
Reginald Haman
Group Chief Corporate Services Officer & Executive Directorless than a yearR14.21mno data
Zizipho Mmango
Group Chief Strategic Development Officer4.3yrsR13.87mno data
Sibongakonke Nkosi
Investor Relations Managerno datano datano data
Trevor Ziman
Regional Chief Executive Officer of Asia Pacific10.7yrsno datano data
Samer Kassem
Chief Executive Officer of Aspen Global Incorporated7.5yrsno datano data
Raeesa Khan
Group Company Secretaryless than a yearno datano data
Luresha Chetty
Corporate Affairs & Investor Relations Executiveno datano datano data

7.5yrs

Average Tenure

54.5yo

Average Age

Experienced Management: APNH.F's management team is seasoned and experienced (7.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephen Saad
Group CEO & Executive Director25.7yrsR24.15m12.84%
$ 754.5m
Sean Capazorio
Group CFO & Executive Director2.7yrsR15.55mno data
Reginald Haman
Group Chief Corporate Services Officer & Executive Directorless than a yearR14.21mno data
Ben Kruger
Lead Independent Non-Executive Director5.4yrsR932.00kno data
Christopher Mortimer
Non-Executive Director25.7yrsR465.00kno data
Kuseni Dlamini
Independent Non-Executive Chairman12.4yrsR1.41mno data
Yvonne Muthien
Independent Non-Executive Director2.8yrsR548.00kno data
David Redfern
Non-Executive Director9.6yrsR364.00kno data
Linda de Beer
Independent Non-Executive Director6.2yrsR958.00kno data
Neo Dongwana
Independent Non-Executive Directorless than a yearno datano data
Themba Mkhwanazi
Independent Non-Executive Director5.4yrsR448.00kno data

5.4yrs

Average Tenure

57yo

Average Age

Experienced Board: APNH.F's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/03 16:01
End of Day Share Price 2024/06/06 00:00
Earnings2023/12/31
Annual Earnings2023/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aspen Pharmacare Holdings Limited is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andre BekkerArqaam Capital Research Offshore S.A.L.
Boitshepo SeruweAvior Capital Markets
Simon MatherBarclays